SavedAdd your journal

Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2015 / Cilt: 61 - Sayı: 4

Anti-TNF Tedaviyle İndüklenen Lupus Benzeri Sendrom

Lupus-like Syndrome Induced by Anti-tumor Necrosis Factor Treatment

Memet KURT
İsmail CÖMERTOĞLU
Ayşe PEYMAN YALÇIN
Pages
371–374
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we present a patient with ankylosing spondylitis who developed a lupus-like syndrome while undergoing treatment with infliximab

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anti-tumor necrosis factor (TNF) agents have been successfully used in the treatment of inflammatory rheumatic diseases for more than 10 years.
📊
Key Findings & Data:Although it is rare disease, a lupus-like syndrome may develop and life-threatening visceral involvement may be observed during treatment with anti-TNF drugs.
💡
Conclusion & Impact:Herein, we present a patient with ankylosing spondylitis who developed a lupus-like syndrome while undergoing treatment with infliximab
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Anti-tumor necrosis factor (TNF) agents have been successfully used in the treatment of inflammatory rheumatic diseases for more than 10 years. Although it is rare disease, a lupus-like syndrome may develop and life-threatening visceral involvement may be observed during treatment with anti-TNF drugs. Herein, we present a patient with ankylosing spondylitis who developed a lupus-like syndrome while undergoing treatment with infliximab

Özet

İnflamatuvar romatizmal hastalıkların tedavisinde anti TNF ajanlar on yılı aşkın süredir başarıyla kullanılmaktadır. Bu ilaçların kullanımı sırasında nadir de olsa lupus benzeri klinik tablo ortaya çıkabilmekte ve hayatı tehdit edebilecek iç organ bulguları gösterebilmektedir. Bu makalede İnfliksimab ile tedavi edilen ankilozan spondilitli bir hastada gelişen lupus benzeri tablo sunulmaktadır

🔖

Cite This Article

KURT, M., CÖMERTOĞLU, İ., YALÇIN, A. P. (2022). Anti-TNF Tedaviyle İndüklenen Lupus Benzeri Sendrom. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 61 - Sayı: 4, 371–374. https://ajindex.com/articles/628768

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 2011;50:619-25. [CrossRef] Vasoo S. Drug-induced lupus: an update. Lupus 2006;15:757-61. [CrossRef] Desai SB, Furst DE. Problems encountered during anti-tumour necrosis factor therapy. Best Pract Res Clin Rheumatol 2006;20:757-90. [CrossRef] De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005;7:R545-51. [CrossRef] Griesmann H, Ripka S, Pralle M, Ellenrieder V, Baumgart S, Buchholz M, et al. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Neoplasia 2013;15:11-22. [CrossRef] Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus: an update on its dermatologic aspects. Lupus 2009;18:935-40. [CrossRef] Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lu- pus erythematosus. Arch Dermatol Res 2009;301:99-105. [CrossRef] Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Berto- laccini L, et al. Autoimmune diseases induced by TNF-targeted thera- pies: analysis of 233 cases. Medicine 2007;86:242-51. [CrossRef] Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheu- matology (Oxford) 2009;48:716-20. [CrossRef] Perez-Alvarez R, Perez-de-Lis M, Ramos-Casals M; BIOGEAS study group. Biologics-induced autoimmune diseases. Curr Opin Rheu- matol 2013;25:56-64. [CrossRef]